(1)
Osteoprotegerin, C- Reactive Protein and Fibroblast Growth Factor-23 in Stage (II-IV) CKD Patients and Their Potential for Increased Incidence of Cardiovascular Disorders. IJPHRD 2020, 11 (8), 206-213. https://doi.org/10.37506/ijphrd.v11i8.10923.